DIVIS LABORATORIES
Back to Income Statement
|
DIVIS LABORATORIES Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹9,360 Cr | ₹7,845 Cr | ₹7,767 Cr | ₹8,960 Cr | ₹6,969 Cr |
What is the latest Revenue of DIVIS LABORATORIES ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹9,360 Cr |
| Mar2024 | ₹7,845 Cr |
| Mar2023 | ₹7,767 Cr |
| Mar2022 | ₹8,960 Cr |
| Mar2021 | ₹6,969 Cr |
How is Revenue of DIVIS LABORATORIES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹9,360 Cr | 19.31 | |
| Mar2024 | ₹7,845 Cr | 1.00 | |
| Mar2023 | ₹7,767 Cr | -13.31 | |
| Mar2022 | ₹8,960 Cr | 28.56 | |
| Mar2021 | ₹6,969 Cr | - | |
Compare Revenue of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹164,211.8 Cr | -4.5% | 0.7% | 3.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,062.0 Cr | 0.4% | 2.6% | NA | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,129.0 Cr | 5% | 4.1% | 37.2% | Stock Analytics | |
| CIPLA | ₹108,513.0 Cr | -0.5% | -3.4% | -6.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,250.0 Cr | 1.2% | 10.2% | 4.8% | Stock Analytics | |
| MANKIND PHARMA | ₹85,198.8 Cr | -1.1% | -2.6% | -15.1% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | -4.5% |
0.7% |
3.4% |
| SENSEX | -1% |
-0.1% |
7.9% |
You may also like the below Video Courses